Description
Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.
In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.
USA is still the largest supplier and consumption market due to the highly developed pharmaceuticals technology and increased awareness of the threat of global terror activity. In 2015, USA enjoyed over 80% consumption market.
By type, Anthrax defense products are most used with market share over 40%, followed by Smallpox defense products and Botulism defense products separately with market share about 30% and 14%. In addition, other diseases like Ebola and Marburg are occupying more and more market share.
In this year, the international situation is not complex, and partial conflict is frequent. Terrorist organization like IS was just making terrorist activity in Paris, which largely increased people’s awareness of the threat of terrorist activity. As a result, the biodefense industry is expecting in the next years.
The global Biodefense market is valued at 850 million US$ in 2018 and will reach 1500 million US$ by the end of 2025, growing at a CAGR of 7.3% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Biodefense market based on company, product type, end user and key regions.
This report studies the global market size of Biodefense in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Biodefense in these regions.
This research report categorizes the global Biodefense market by top players/brands, region, type and end user. This report also studies the global Biodefense market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3717510-global-biodefense-market-insights-forecast-to-2025
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals
Market size by Product
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others
Market size by End User
US Military Market
US Civilian Market
Non – US Market
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
The study objectives of this report are:
To study and analyze the global Biodefense market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Biodefense market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Biodefense companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Biodefense submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Leave a Query @ https://www.wiseguyreports.com/enquiry/3717510-global-biodefense-market-insights-forecast-to-2025
Table of Contents
1 Study Coverage
1.1 Biodefense Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Biodefense Market Size Growth Rate by Product
1.4.2 Anthrax
1.4.3 Smallpox
1.4.4 Botulism
1.4.5 Radiation/Nuclear
1.4.6 Others
1.5 Market by End User
1.5.1 Global Biodefense Market Size Growth Rate by End User
1.5.2 US Military Market
1.5.3 US Civilian Market
1.5.4 Non – US Market
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Biodefense Market Size
2.1.1 Global Biodefense Revenue 2014-2025
2.1.2 Global Biodefense Sales 2014-2025
2.2 Biodefense Growth Rate by Regions
2.2.1 Global Biodefense Sales by Regions
2.2.2 Global Biodefense Revenue by Regions
….
11 Company Profiles
11.1 Emergent Biosolutions
11.1.1 Emergent Biosolutions Company Details
11.1.2 Company Business Overview
11.1.3 Emergent Biosolutions Biodefense Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Emergent Biosolutions Biodefense Products Offered
11.1.5 Emergent Biosolutions Recent Development
11.2 Hytest
11.2.1 Hytest Company Details
11.2.2 Company Business Overview
11.2.3 Hytest Biodefense Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Hytest Biodefense Products Offered
11.2.5 Hytest Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 Company Business Overview
11.3.3 GSK Biodefense Sales, Revenue and Gross Margin (2014-2019)
11.3.4 GSK Biodefense Products Offered
11.3.5 GSK Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Company Business Overview
11.4.3 Sanofi Biodefense Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Sanofi Biodefense Products Offered
11.4.5 Sanofi Recent Development
11.5 PharmAthene
11.5.1 PharmAthene Company Details
11.5.2 Company Business Overview
11.5.3 PharmAthene Biodefense Sales, Revenue and Gross Margin (2014-2019)
11.5.4 PharmAthene Biodefense Products Offered
11.5.5 PharmAthene Recent Development
11.6 Bavarian Nordic
11.6.1 Bavarian Nordic Company Details
11.6.2 Company Business Overview
11.6.3 Bavarian Nordic Biodefense Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Bavarian Nordic Biodefense Products Offered
11.6.5 Bavarian Nordic Recent Development
11.7 SIGA Technologies
11.7.1 SIGA Technologies Company Details
11.7.2 Company Business Overview
11.7.3 SIGA Technologies Biodefense Sales, Revenue and Gross Margin (2014-2019)
11.7.4 SIGA Technologies Biodefense Products Offered
11.7.5 SIGA Technologies Recent Development
11.8 Arbutus Biopharma
11.8.1 Arbutus Biopharma Company Details
11.8.2 Company Business Overview
11.8.3 Arbutus Biopharma Biodefense Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Arbutus Biopharma Biodefense Products Offered
11.8.5 Arbutus Biopharma Recent Development
11.9 DynPort Vaccine
11.9.1 DynPort Vaccine Company Details
11.9.2 Company Business Overview
11.9.3 DynPort Vaccine Biodefense Sales, Revenue and Gross Margin (2014-2019)
11.9.4 DynPort Vaccine Biodefense Products Offered
11.9.5 DynPort Vaccine Recent Development
11.10 Xoma Corporation
11.10.1 Xoma Corporation Company Details
11.10.2 Company Business Overview
11.10.3 Xoma Corporation Biodefense Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Xoma Corporation Biodefense Products Offered
11.10.5 Xoma Corporation Recent Development
11.11 Ichor Medical Systems
11.12 Aeolus Pharmaceuticals
11.13 Achaogen
11.14 Elusys Therapeutics
11.15 Dynavax Technologies
11.16 Cleveland BioLabs
11.17 Soligenix
11.18 Alnylam Pharmaceuticals
Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3717510
Continued…
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)
Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: https://www.wiseguyreports.com/sample-request/3717510-global-biodefense-market-insights-forecast-to-2025